Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FAPI-PET for Diffuse Gastric Cancer (FAPI-DGC Study)
jRCTs031250386Recruiting
- Sponsor
- University of Tsukuba Hospital
- Start
- Nov 2025
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Positron Emitters → Radiopharmaceuticals, Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of [18F]AlF-NOTA-FAPI-04 in gastric cancer (GC), sponsored by University of Tsukuba Hospital. Primary endpoint: Preoperative staging accuracy (T, N, M) with conventional imaging vs. with added FAPI-PET. Started Nov 2025; status: recruiting.
02
Drugs
[18F]AlF-NOTA-FAPI-04
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on jRCTs031250386.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031250386.